Why this tech company raised $50M to tackle dozens of rare diseases

AllStripes announces $50 million Series B financing

AllStripes expands rare disease research programs to United Kingdom

AllStripes announces collaboration with Taysha Gene Therapies for SURF1-Associated Leigh syndrome program

AllStripes announces partnership with Penn’s Orphan Disease Center